INJURIES TO THE GASTROINTESTINAL TRACT INTERPRETED AS A MANIFESTATION OF ACROMEGALY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Acromegaly is a polysymptomatic disease with multiple comorbidities, among which gastric and colonic disorders are common. In acromegaly excess production of the growth hormone (GH) and an insulinlike growth factor type 1 (IGF-1) is observed that leads to increased prevalence of colonic diverticula, gastric and colonic polyps, polyps of gallbladder and also a colorectal cancer. Identification of these intestine diseases in persons of young age, and also a combination them with other possible symptoms of acromegaly demands hormonal investigation for acromegaly exclusion. On the other hand, all patients with proved acromegaly need to conduct examination of gastrointestinal tract.

Full Text

Restricted Access

About the authors

Irena Adolfovna Ilovayskaya

M.F. Vladimirskiy Moscow Regional Research and Clinical Institute

Email: irena.ilov@yandex.ru
PhD, senior fellow at Department of Therapeutic Endocrinology 129110 Moscow, 61/2 Schepkina St

References

  1. Древаль A.B., Иловайская И.А., Триголосова И.В., Покрамович Ю.Г. Алгоритмы диагностики и лечения акромегалии (Пособие для врачей). М.: 2013. 38 с
  2. Fernandez A., Karavitaki N., Wass J.A. Prevalence of pituitary ademonas: a community-based, cross-sectional study in Banbury (Oxfordshire. UK). Clin. Endocrinol. (Oxf). 2010;72[3]:377-82.
  3. Mehta G.U., Jane J.A. Jr. Pituitary tumors. Curr. Opin. Neurol. 2012;25(6):751 -55.
  4. Chanson P., Salenave S., Kamenicky P., Cazabat L., Young J. Pituitary tumours: acromegaly. Best Pract. Res. Clin. Endocrinol. Metab. 2009;23[5]:555-74.
  5. Lugo G., Pena L., Cordido F. Clinical manifestations and diagnosis of acromegaly. Int. J. Endocrinol. 2012;2012:540398.
  6. Dekkers O.M., Biermasz N.R., Pereira A.M., Romijn J.A., Vandenbroucke J.P. Mortality in acromegaly: a meta-analysis. J. Clin. Endocrinol. Metab. 2008;93:61-7.
  7. Floldaway I.M., Bolland M.J., Gamble G.D. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 2008;159:89-95.
  8. Floldaway I.M., Rajasoorya R.C., Gamble G.D. Factors influencing mortality in acromegaly. J. Clin. Endocrinol. Metab. 2004;89[2]:667-74.
  9. MCE Acromegaly Guidelines Task Force, AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly. Endocr. Pract. 2011 ; 10(31:213-25.
  10. Delhougne B., Deneux C., Abs R. et al. The prevalence of colonie polyps in acromegaly: a colonoscopic and pathological study in 103 patients. J. Clin. Endocrinol. Metab. 1995;80(11 ]:3223-6.
  11. Титаева A.C., Терещенко С.Г., Лукина Е.М., Древаль A.B., Иловайская И.А. Фоновые изменения слизистой оболочки ЖКТ у больных акромегалией. Альманах клинической медицины. 2014;31:29-33.
  12. Matyja V., Kos-Kudla B., Foltyn W., Strzelczyk J., Latos W., Marek В., Kajdaniuk D., Karpe J., Ostrowska Z., Sieron-Stoltny K., Sieron A. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels. Neurora Endocrinolra Lett. 2006;27(5):639-43.
  13. Terzolo M., Reimondo G., Gasperi M., Cozzi R., Pivonello R., Vitale G., Scillitani A., Attanasio R., Cecconi E., Daffara F., Gaia E., Martino E., Lombardi G., Angeli A., Colao A. Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. J. Clin. Endocrinol. Metab. 2005;90:84-90.
  14. Bogazzi F., Cosci C., Sardella C., Costa A., Manetti L., Gasperi M., Rossi G., Bartalena L., Martino E. Identification of acromegalic patients at risk of developing colonic adenomas. J. Clin. Endocrinol. Metab. 2006;91:1351-6.
  15. Renehan A.G., Shalet S.M. Acromegaly and colorectal cancer: risk assessment should be based on population-based studies. J. Clin. Endocrinol. Metab. 2002;87:1909.
  16. Colao A., Ferone D., Marzullo P., Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr. Rev. 2004;25:102-52.
  17. Wassenaar M.J., Cazemier M., Biermasz N.R., Pereira A.M., Roelfsema F., Smit J.W., Flommes D.W., Felt-Bersma R.J., Romijn J.A. Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study. J. Clin. Endocrino. Metab. 2010;95(5):2073-9.
  18. Colao A., Spinelli L., Marzullo P., Pivonello R., Petretta M., Di Somma C., Vitale G., Bonaduce D., Lombardi G. Fligh prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study. J. Clin. Endocrinol. Metab. 2003;88[7]:3196-201.
  19. Killinger Z., Payer J., Lazúrová I., Imrich R., Homérová Z., Kužma M., Rovenský J. Arthropathy in acromegaly. Rheum. Dis. Clin. N. Am. 2010;36(4]:713-20.
  20. Resmini E., Tagliafico A., Bacigalupo L., Giordano G., Melani E., Rebora A., Minuto F., Rollandі G.A., Ferone D. Computed tomography со tonography in acromegaly. J. Clin. Endocrinol. Metab. 2009; 94:218-22.
  21. Renehan A.G., Painter J.E., Bell G.D., Rowland R.S., O'Dwyer S.T., Shalet S.M. Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy. Clin. Endocrinol. (Oxf). 2005;62:323-30.
  22. Melmed S. Acromegaly and cancer: not a problem? J. Clin. Endocrinol. Metab. 2001 ;86:2929-34.
  23. Rokkas T., Pistiolas D., Sechopoulos P., Margantinis G., Koukoulis G. Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J. Gastroenterol. 2008;14(22):3484-9.
  24. Levin B., Lieberman D.A., McFarland B., Andrews K.S., Brooks D., Bond J., Dash C., Giardiello F.M., Glick S., Johnson D., Johnson C.D., Levin T.R., Pickhardt P.J., Rex D.K., Smith R.A, Thorson A., Winawer S.J. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology. 2008;134(5):1570-95.
  25. Melmed S., Colao A., Barkan A., Molitch M., Grossman A.B., Kleinberg D., Clemmons D., Chanson P., Laws E., Schlechte J., Vance M.L., Ho K., Giustina A. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 2009;94:1509-17.
  26. Annamalai A.K., Gayton E.L., Webb A., Halsall D.J., Rice C., Ibram F., Chaudhry A.N., Simpson H.L., Berman L., Gurnell M. Increased prevalence of gallbladder polyps in acromegaly. J. Clin. Endocrinol. Metabol. 2011 ;96(7):E1120-E1125.
  27. Colao A., Pivonello R., Auriemma R.S., Galdiero M., Ferone D., Minuto F., Marzullo P., Lombardi G. The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients. J. Clin. Endocrinol. Metab. 2007;92(10):3854-60.
  28. Дедов И.И., Молитвословова Н.Н., Рожинская Л.Я., Мельниченко Г.А Федеральные клинические рекомендации по клинике, диагностике, дифференциальной диагностике и методам лечения акромегалии. Проблемы эндокринологии. 2013;6:4-18.
  29. Sala E., Ferrante E., Locatelli M., Rampini P., Mantovani G., Giavoli C., Filopanti M., Verrua E., Malchiodi E., Carrabba G., Arosio M., Beck-Peccoz P., Spada A., Lania A.G. Diagnostic features and outcome of surgical therapy of acromegalic patients: experience of the last three decades. Hormones (Athens). 2014;13(1):95-103.Colao A., Auriem ma R.S., Galdiero M., Lombardi G., Pivonello R. Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study. J. Clin. Endocrinol. Metab. 2009;94:3746-56.
  30. Maiza J.C., Vezzosi D., Matta M., Donadille F., Loubes-Lacroix F., Cournot M., Bennet A., Caron P. Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa. Clin. Endocrinol (Oxf). 2007;67:282-9.
  31. Мельниченко Г.А., Марова Е.И., Молитвословова Н.Н., Пронин В.С., Колода Д.Е., Гитель Е.П., Волков Р.Ю. Клиническая эффективность аналога соматостатина длительного действия Октреотид-депо у больных акромегалией. Фарматека. 2007;11:66-9.
  32. Древаль А.В., Покрамович Ю.Г., Тишенина Р.С. Эффективность аналога соматостатина длительного действия Октреотида-депо в лечении больных с активной фазой акромегалии. Проблемы эндокринологии. 2014;3:10-4.
  33. Древаль А.В., Иловайская И.А., Покрамович Ю.Г., Сташук Г.А., Абраменко А.С., Тишенина Р.С. Изменение объема соматотропиномы у больных, получающих лечение Октреотидом-депо. Проблемы эндокринологии, 2014;4:12-6

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Bionika Media